|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:1355-1356
© 2007 The American Association for Thoracic Surgery
Brief Communication |
a Department of Pediatric Cardiology, the University of Iowa Childrens Hospital, Iowa City, Iowa
b Department of Cardiovascular Surgery, the Mayo Clinic, Rochester, Minn
c Department of Pediatric Cardiology, the Cleveland Clinic, Cleveland, Ohio
d Department of Obstetrics, Gynecology & Reproductive Sciences, the University of Pittsburgh, Pittsburgh, Pa
e Department of Pediatric Cardiology, the Denver Childrens Hospital, Denver, Colo.
Received for publication July 9, 2007; accepted for publication July 19, 2007. * Address for reprints: Nicholas H. Von Bergen, MD, The University of Iowa Childrens Hospital, 200 Hawkins Dr, Iowa City, IA 52242. (Email: Nicholas-vonbergen{at}uiowa.edu).
Hypoplastic left heart syndrome (HLHS) with intact or restrictive atrial septum is associated with mortality as high as 50% to 80%.1,2
There is a theoretical benefit to in utero creation of an atrial septal defect, although to date this procedure has been associated with a high mortality without conclusive improvement in survival or alteration of hemodynamics.1,3
We describe the case of a patient successfully treated by in utero atrial septostomy who subsequently progressed through the complete cavopulmonary shunt procedure. To our knowledge, this is the first such case to be described in the literature.
Prenatal history
At 20 weeks gestation, a fetal echocardiogram demonstrated severe aortic stenosis with minimal antegrade flow and a dilated, poorly contractile left ventricle. Four weeks later there was progression to HLHS. No interatrial flow could be demonstrated and the pulmonary venous flow pattern was consistent with severe obstruction (Figure 1).
|
|
Postnatal hospital course
Postnatally, the patients diagnosis of HLHS was defined with poor right ventricular function and a restrictive atrial septum. He was in relatively stable condition immediately after birth and underwent balloon atrial septostomy at about 36 hours of age for a mean interatrial gradient of 21 mm Hg. He subsequently underwent Norwood palliation 6 days after birth. This involved aortopulmonary anastomosis with arch reconstruction, a 6-mm polytetrafluoroethylene (Gore-Tex conduit; W. L. Gore & Associates, Inc, Flagstaff, Ariz) conduit from the right ventricle to the pulmonary artery, and atrial septectomy. Intraoperatively, the atrial septum was noted to be markedly hypertrophic. There was no evidence of pericardial adhesions.
At 5 months of age, the patient successfully underwent a bidirectional cavopulmonary anastomosis and left pulmonary arterioplasty. Worsening cyanosis prompted complete cavopulmonary anastomosis with an 18-mm extracardiac conduit and a repeat atrial septectomy at 24 months of age. The atrial septum had become restrictive again, with a mean gradient of 10 to 12 mm Hg. Six months after discharge, the patient continues to do well.
HLHS, characterized by a small left ventricle and a hypoplastic aortic arch, is present in as many as 1 in 10,000 live births.4
Surgical palliation after birth is associated with a high morbidity and mortality even with the current surgical interventions. A significant risk factor, with a mortality of 50% or more, is an intact or restrictive atrial septum, resulting in left atrial hypertension and an increase in pulmonary venous pressure.2,5
There are significant theoretical advantages to in utero palliation, including improved circulation and potential for improved structural and functional development. Therefore, fetal interventions including balloon1
or laser atrial septostomy3
have been pursued. Although some centers have shown improvement in the size of the interatrial communication by using fetal echocardiography, significant procedural mortality with variable clinical improvement has been seen in the earliest published results.1
HLHS with intact or restrictive atrial septum is associated with high mortality. There is a theoretical benefit to in utero creation of an atrial septal defect, although to date this procedure is associated with high mortality and there has been no conclusive improvement in survival or alteration of hemodynamics. To our knowledge, this is the first patient described in the literature who has undergone in utero atrial septostomy and completed the 3 palliative stages. Although results of this procedure have been variable, this palliation can potentially have a significant positive impact in select patients.
Footnotes
1 Larry A. Latson, MD, reports lecture fees from Medtronic and W. L. Gore and grant support from NMT Medical and W. L. Gore. ![]()
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |